AR and polycystic ovary syndrome: To investigate the potential causal involvement of the androgen receptor pathway in the development of PCOS‐like traits and to assess the preventive capacity of downstream effects, one group of mice received simultaneous implantation of a DHT‐pellet and a continuous slow‐releasing flutamide pellet, an androgen receptor antagonist, hereafter referred to as flutamide mice (Figure 1a).